Status:
UNKNOWN
Reading Analysis in Ophthalmologic Patients
Lead Sponsor:
Prim. Prof. Dr. Oliver Findl, MBA
Conditions:
Diabetic Maculopathy
Age Related Macular Degeneration
Eligibility:
All Genders
21-105 years
Phase:
NA
Brief Summary
Investigation of the reading parameters and fixation behavior in patients with different ocular diseases (age-related macular degeneration, glaucoma, diabetic maculopathy, epiretinal membrane) and hea...
Detailed Description
Reading is a complex function. It requires a proper retinal image that is received by the brain. There it is analyzed for letter and word recognition and then the semantics is detected. Reading speed ...
Eligibility Criteria
Inclusion
- Age 21 and older
- Absence of ocular disease (Group 1)
- Present ocular disease (age-related macular degeneration, glaucoma, diabetic maculopathy, epiretinal membrane/macular hole) as judged by the investigator (Group 2 - 5)
- Maximum of allowed cylinder-power in the spectacles: +1.50D
Exclusion
- Ocular pathologies, that may interfere with study measurements, such as corneal scars
- In case of pregnancy (pregnancy test will be taken prior to inclusion into the study in women of reproductive age)
Key Trial Info
Start Date :
January 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2021
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT03750149
Start Date
January 1 2018
End Date
January 1 2021
Last Update
February 27 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Vienna Institute for Research in Ocular Surgery (VIROS)
Vienna, Austria, 1140